386 related articles for article (PubMed ID: 35189925)
21. Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical Trial.
Grégoire C; Layios N; Lambermont B; Lechanteur C; Briquet A; Bettonville V; Baudoux E; Thys M; Dardenne N; Misset B; Beguin Y
Front Immunol; 2022; 13():932360. PubMed ID: 35860245
[TBL] [Abstract][Full Text] [Related]
22. Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome.
Ringdén O; Moll G; Gustafsson B; Sadeghi B
Front Immunol; 2022; 13():839844. PubMed ID: 35371003
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness and safety of normoxic allogenic umbilical cord mesenchymal stem cells administered as adjunctive treatment in patients with severe COVID-19.
Soetjahjo B; Malueka RG; Nurudhin A; Purwoko ; Sumardi ; Wisaksana R; Adhiputri A; Sudadi ; Soeroto AY; Sidharta BRA; Thobari JA; Murni TW; Soewondo W; Herningtyas EH; Sudjud RW; Trisnawati I; Ananda NR; Faried A
Sci Rep; 2023 Aug; 13(1):12520. PubMed ID: 37532730
[TBL] [Abstract][Full Text] [Related]
24. Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial.
Rebelatto CLK; Senegaglia AC; Franck CL; Daga DR; Shigunov P; Stimamiglio MA; Marsaro DB; Schaidt B; Micosky A; de Azambuja AP; Leitão CA; Petterle RR; Jamur VR; Vaz IM; Mallmann AP; Carraro Junior H; Ditzel E; Brofman PRS; Correa A
Stem Cell Res Ther; 2022 Mar; 13(1):122. PubMed ID: 35313959
[TBL] [Abstract][Full Text] [Related]
25. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.
Wilson JG; Liu KD; Zhuo H; Caballero L; McMillan M; Fang X; Cosgrove K; Vojnik R; Calfee CS; Lee JW; Rogers AJ; Levitt J; Wiener-Kronish J; Bajwa EK; Leavitt A; McKenna D; Thompson BT; Matthay MA
Lancet Respir Med; 2015 Jan; 3(1):24-32. PubMed ID: 25529339
[TBL] [Abstract][Full Text] [Related]
26. Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group.
Abraham E; Baughman R; Fletcher E; Heard S; Lamberti J; Levy H; Nelson L; Rumbak M; Steingrub J; Taylor J; Park YC; Hynds JM; Freitag J
Crit Care Med; 1999 Aug; 27(8):1478-85. PubMed ID: 10470753
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II.
Fathi-Kazerooni M; Fattah-Ghazi S; Darzi M; Makarem J; Nasiri R; Salahshour F; Dehghan-Manshadi SA; Kazemnejad S
Stem Cell Res Ther; 2022 Mar; 13(1):96. PubMed ID: 35255966
[TBL] [Abstract][Full Text] [Related]
28. Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial.
Zarrabi M; Shahrbaf MA; Nouri M; Shekari F; Hosseini SE; Hashemian SR; Aliannejad R; Jamaati H; Khavandgar N; Alemi H; Madani H; Nazari A; Amini A; Hassani SN; Abbasi F; Jarooghi N; Fallah N; Taghiyar L; Ganjibakhsh M; Hajizadeh-Saffar E; Vosough M; Baharvand H
Stem Cell Res Ther; 2023 Jun; 14(1):169. PubMed ID: 37365605
[TBL] [Abstract][Full Text] [Related]
29. Specific Clinical and Immunological Changes Following Mesenchymal Stem Cell Transplantation in COVID-19-induced Acute Respiratory Distress Syndrome Patients: A Phase-I Clinical Trial.
Kaffash Farkhad N; Sedaghat A; Reihani H; Adhami Moghadam A; Bagheri Moghadam A; Khadem Ghaebi N; Khodadoust MA; Nikpoor AR; Tavakol Afshari J
Iran J Allergy Asthma Immunol; 2022 Dec; 21(6):687-703. PubMed ID: 36640060
[TBL] [Abstract][Full Text] [Related]
30. FX06 to rescue SARS-CoV-2-induced acute respiratory distress syndrome: a randomized clinical trial.
Guérin E; Belin L; Franchineau G; Le Guennec L; Hajage D; Diallo MH; Frapard T; Le Fèvre L; Luyt CE; Combes A; Germain S; Hayon J; Asfar P; Bréchot N
Crit Care; 2023 Aug; 27(1):331. PubMed ID: 37641136
[TBL] [Abstract][Full Text] [Related]
31. Effect of Intravenous Interferon β-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome: A Randomized Clinical Trial.
Ranieri VM; Pettilä V; Karvonen MK; Jalkanen J; Nightingale P; Brealey D; Mancebo J; Ferrer R; Mercat A; Patroniti N; Quintel M; Vincent JL; Okkonen M; Meziani F; Bellani G; MacCallum N; Creteur J; Kluge S; Artigas-Raventos A; Maksimow M; Piippo I; Elima K; Jalkanen S; Jalkanen M; Bellingan G;
JAMA; 2020 Feb; 323(8):725-733. PubMed ID: 32065831
[TBL] [Abstract][Full Text] [Related]
32. Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a Phase I/II randomised double-blind placebo-controlled trial.
Carlsson PO; Espes D; Sisay S; Davies LC; Smith CIE; Svahn MG
Diabetologia; 2023 Aug; 66(8):1431-1441. PubMed ID: 37221247
[TBL] [Abstract][Full Text] [Related]
33. Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome.
Qu W; Wang Z; Hare JM; Bu G; Mallea JM; Pascual JM; Caplan AI; Kurtzberg J; Zubair AC; Kubrova E; Engelberg-Cook E; Nayfeh T; Shah VP; Hill JC; Wolf ME; Prokop LJ; Murad MH; Sanfilippo FP
Stem Cells Transl Med; 2020 Sep; 9(9):1007-1022. PubMed ID: 32472653
[TBL] [Abstract][Full Text] [Related]
34. Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
Dixon B; Smith RJ; Campbell DJ; Moran JL; Doig GS; Rechnitzer T; MacIsaac CM; Simpson N; van Haren FMP; Ghosh AN; Gupta S; Broadfield EJC; Crozier TME; French C; Santamaria JD;
Lancet Respir Med; 2021 Apr; 9(4):360-372. PubMed ID: 33493448
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of umbilical cord-derived mesenchymal stem cells in Chinese adults with type 2 diabetes: a single-center, double-blinded, randomized, placebo-controlled phase II trial.
Zang L; Li Y; Hao H; Liu J; Cheng Y; Li B; Yin Y; Zhang Q; Gao F; Wang H; Gu S; Li J; Lin F; Zhu Y; Tian G; Chen Y; Gu W; Du J; Chen K; Guo Q; Yang G; Pei Y; Yan W; Wang X; Meng J; Zhang S; Ba J; Lyu Z; Dou J; Han W; Mu Y
Stem Cell Res Ther; 2022 May; 13(1):180. PubMed ID: 35505375
[TBL] [Abstract][Full Text] [Related]
36. Mesenchymal stromal cells as treatment for acute respiratory distress syndrome. Case Reports following hematopoietic cell transplantation and a review.
Sadeghi B; Ringdén O; Gustafsson B; Castegren M
Front Immunol; 2022; 13():963445. PubMed ID: 36426365
[TBL] [Abstract][Full Text] [Related]
37. Open-label randomized controlled trial of ultra-low tidal ventilation without extracorporeal circulation in patients with COVID-19 pneumonia and moderate to severe ARDS: study protocol for the VT4COVID trial.
Richard JC; Yonis H; Bitker L; Roche S; Wallet F; Dupuis C; Serrier H; Argaud L; Thiery G; Delannoy B; Pommier C; Abraham P; Muller M; Aubrun F; Sigaud F; Rigault G; Joffredo E; Mezidi M; Terzi N; Rabilloud M
Trials; 2021 Oct; 22(1):692. PubMed ID: 34635128
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of multipotent adult progenitor cells in acute respiratory distress syndrome (MUST-ARDS): a multicentre, randomised, double-blind, placebo-controlled phase 1/2 trial.
Bellingan G; Jacono F; Bannard-Smith J; Brealey D; Meyer N; Thickett D; Young D; Bentley A; McVerry BJ; Wunderink RG; Doerschug KC; Summers C; Rojas M; Ting A; Jenkins ED
Intensive Care Med; 2022 Jan; 48(1):36-44. PubMed ID: 34811567
[TBL] [Abstract][Full Text] [Related]
39. Potential application of mesenchymal stromal cells as a new therapeutic approach in acute respiratory distress syndrome and pulmonary fibrosis.
Gazzaniga G; Voltini M; Carletti A; Lenta E; Meloni F; Briganti DF; Avanzini MA; Comoli P; Belliato M
Respir Res; 2024 Apr; 25(1):170. PubMed ID: 38637860
[TBL] [Abstract][Full Text] [Related]
40. A pilot study on intravenous N-Acetylcysteine treatment in patients with mild-to-moderate COVID19-associated acute respiratory distress syndrome.
Taher A; Lashgari M; Sedighi L; Rahimi-Bashar F; Poorolajal J; Mehrpooya M
Pharmacol Rep; 2021 Dec; 73(6):1650-1659. PubMed ID: 34114174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
